Novo Nordisk Files Routine 6-K Report
Ticker: NVO · Form: 6-K · Filed: Apr 20, 2026 · CIK: 0000353278
Sentiment: neutral
Topics: reporting, foreign-issuer
TL;DR
Novo Nordisk filed a standard 6-K, no major news.
AI Summary
Novo Nordisk A/S filed a Form 6-K on April 20, 2026, reporting information as a foreign issuer. The filing includes standard documents like the 6-K form itself and graphic files, with no specific financial transactions or operational updates detailed in the provided text.
Why It Matters
This filing indicates ongoing compliance and reporting by Novo Nordisk as a foreign issuer, which is standard practice for companies listed on US exchanges.
Risk Assessment
Risk Level: low — The filing is a routine report of a foreign issuer and does not contain any new material information that would impact risk.
Key Players & Entities
- NOVO NORDISK A S (company) — Filer
- 0000353278 (company) — CIK number for Novo Nordisk A S
- 2026-04-20 (date) — Filing Date and Period of Report
FAQ
What type of SEC filing is this?
This is a Form 6-K, which is a Report of foreign issuer.
Who is the filer of this report?
The filer is NOVO NORDISK A S.
When was this filing accepted by the SEC?
The filing was accepted on 2026-04-20 at 09:38:24.
What is the CIK number for Novo Nordisk A S?
The CIK number for Novo Nordisk A S is 0000353278.
What are the included documents in this filing?
The filing includes FORM 6-K, logo.jpg, and ca.jpg.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on April 20, 2026 regarding NOVO NORDISK A S (NVO).